Home › Funds › Bain Capital Life Sciences Investors, LLC › NAMSW
Bain Capital Life Sciences Investors, LLC position in NAMSW
NEWAMSTERDAM PHARMA COMPANY · Materials
Bain Capital Life Sciences Investors, LLC reported holding 99,999 shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.09% of its reported portfolio and ranking #22 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed NAMSW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Bain Capital Life Sciences Investors, LLC's NAMSW position evolved
Bain Capital Life Sciences Investors, LLC first disclosed a stake in NAMSW in Q3 2023 at 100,000 shares (US$190K). The position peaked in Q4 2025 at 99,999 shares, worth US$2.3M. Across 13 filings, Bain Capital Life Sciences Investors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 99,999 shares valued at US$1.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 100.00K | $190.00K | New |
| Q4 2023 | 100.00K | $313.00K | Hold |
| Q1 2024 | 100.00K | $1.10M | Hold |
| Q2 2024 | 100.00K | $872.00K | Hold |
| Q3 2024 | 100.00K | $700.00K | Hold |
| Q4 2024 | 100.00K | $1.43M | Hold |
| Q1 2025 | 100.00K | $899.00K | Hold |
| Q2 2025 | 100.00K | $800.00K | Hold |
| Q3 2025 | 100.00K | $1.71M | Hold |
| Q4 2025 | 100.00K | $2.30M | Hold |
| Q1 2026 | 100.00K | $2.00M | Hold |
| Q2 2026 | 100.00K | $2.14M | Hold |
| Q3 2026 | 100.00K | $1.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NAMSW and 13F data
NAMSW (NEWAMSTERDAM PHARMA COMPANY) is a Materials company. 10 other funds we track also report a position in NAMSW — the largest reported positions include Frazier Life Sciences Management, L.P. (US$10.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NAMSW
- Frazier Life Sciences Management, L.P. 500.33K sh · $10.69M · Q2 2026
More on Bain Capital Life Sciences Investors, LLC
FAQ
How long has Bain Capital Life Sciences Investors, LLC held NAMSW?
Bain Capital Life Sciences Investors, LLC has disclosed NAMSW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Bain Capital Life Sciences Investors, LLC's current position in NAMSW?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 100.00K shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY), valued at $1.26M, representing 0.09% of its reported portfolio and ranking #22.
Has Bain Capital Life Sciences Investors, LLC been buying or selling NAMSW?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in NAMSW. The position peaked in Q4 2025 at 100.00K shares.
Which other funds hold NAMSW?
Other major institutional holders of NAMSW include Frazier Life Sciences Management, L.P., among 10 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.